Downregulation of miR-484 is associated with poor prognosis and tumor progression of gastric cancer

Abstract Background Gastric cancer is one of the most common cancers leading to high cancer mortality. MicroRNA-484 (miR-484) has been evaluated as a biomarker for various types of cancers. The subject of this study is to investigate the functional role of miR-484 in gastric cancer. Methods The expr...

Full description

Bibliographic Details
Main Authors: Ying Li, Yusong Liu, Jie Yao, Rui Li, Xiaocheng Fan
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Diagnostic Pathology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13000-020-00946-8
_version_ 1818978929497604096
author Ying Li
Yusong Liu
Jie Yao
Rui Li
Xiaocheng Fan
author_facet Ying Li
Yusong Liu
Jie Yao
Rui Li
Xiaocheng Fan
author_sort Ying Li
collection DOAJ
description Abstract Background Gastric cancer is one of the most common cancers leading to high cancer mortality. MicroRNA-484 (miR-484) has been evaluated as a biomarker for various types of cancers. The subject of this study is to investigate the functional role of miR-484 in gastric cancer. Methods The expression of miR-484 in gastric cancer was analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) assay. Kaplan-Meier survival and Cox regression analyses were employed to explore the prognostic significance of miR-484 in gastric cancer. The functional role of miR-484 in gastric cancer was determined by CCK-8 and Transwell assays. Results The results showed that miR-484 was significantly downregulated in gastric cancer tissues and cell lines. The downregulation of miR-484 was closely related to differentiation, lymph node metastasis, TNM stage, and poor prognosis. Cox regression analyses demonstrated that miR-484 was an independent prognosis indicator for gastric cancer patients. Additionally, the downregulation of miR-484 enhanced cell proliferation, migration, and invasion in gastric cancer cells. Conclusion These data demonstrated that miR-484 can serve as a potential prognostic biomarker and therapeutic target for gastric cancer and it may be involved in the progression of gastric cancer.
first_indexed 2024-12-20T16:51:27Z
format Article
id doaj.art-eec554b8d4c7413b9f29c8ef1108c161
institution Directory Open Access Journal
issn 1746-1596
language English
last_indexed 2024-12-20T16:51:27Z
publishDate 2020-03-01
publisher BMC
record_format Article
series Diagnostic Pathology
spelling doaj.art-eec554b8d4c7413b9f29c8ef1108c1612022-12-21T19:32:48ZengBMCDiagnostic Pathology1746-15962020-03-011511710.1186/s13000-020-00946-8Downregulation of miR-484 is associated with poor prognosis and tumor progression of gastric cancerYing Li0Yusong Liu1Jie Yao2Rui Li3Xiaocheng Fan4Department of Oncology, Jining Hospital of Traditional Chinese MedicineDepartment of Oncology, Jining Hospital of Traditional Chinese MedicineDepartment of Oncology, Jining Hospital of Traditional Chinese MedicineDepartment of Oncology, Jining Hospital of Traditional Chinese MedicineDepartment of Oncology, Jining Hospital of Traditional Chinese MedicineAbstract Background Gastric cancer is one of the most common cancers leading to high cancer mortality. MicroRNA-484 (miR-484) has been evaluated as a biomarker for various types of cancers. The subject of this study is to investigate the functional role of miR-484 in gastric cancer. Methods The expression of miR-484 in gastric cancer was analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) assay. Kaplan-Meier survival and Cox regression analyses were employed to explore the prognostic significance of miR-484 in gastric cancer. The functional role of miR-484 in gastric cancer was determined by CCK-8 and Transwell assays. Results The results showed that miR-484 was significantly downregulated in gastric cancer tissues and cell lines. The downregulation of miR-484 was closely related to differentiation, lymph node metastasis, TNM stage, and poor prognosis. Cox regression analyses demonstrated that miR-484 was an independent prognosis indicator for gastric cancer patients. Additionally, the downregulation of miR-484 enhanced cell proliferation, migration, and invasion in gastric cancer cells. Conclusion These data demonstrated that miR-484 can serve as a potential prognostic biomarker and therapeutic target for gastric cancer and it may be involved in the progression of gastric cancer.http://link.springer.com/article/10.1186/s13000-020-00946-8Gastric cancermicroRNA-484ProliferationMigrationInvasionPrognosis
spellingShingle Ying Li
Yusong Liu
Jie Yao
Rui Li
Xiaocheng Fan
Downregulation of miR-484 is associated with poor prognosis and tumor progression of gastric cancer
Diagnostic Pathology
Gastric cancer
microRNA-484
Proliferation
Migration
Invasion
Prognosis
title Downregulation of miR-484 is associated with poor prognosis and tumor progression of gastric cancer
title_full Downregulation of miR-484 is associated with poor prognosis and tumor progression of gastric cancer
title_fullStr Downregulation of miR-484 is associated with poor prognosis and tumor progression of gastric cancer
title_full_unstemmed Downregulation of miR-484 is associated with poor prognosis and tumor progression of gastric cancer
title_short Downregulation of miR-484 is associated with poor prognosis and tumor progression of gastric cancer
title_sort downregulation of mir 484 is associated with poor prognosis and tumor progression of gastric cancer
topic Gastric cancer
microRNA-484
Proliferation
Migration
Invasion
Prognosis
url http://link.springer.com/article/10.1186/s13000-020-00946-8
work_keys_str_mv AT yingli downregulationofmir484isassociatedwithpoorprognosisandtumorprogressionofgastriccancer
AT yusongliu downregulationofmir484isassociatedwithpoorprognosisandtumorprogressionofgastriccancer
AT jieyao downregulationofmir484isassociatedwithpoorprognosisandtumorprogressionofgastriccancer
AT ruili downregulationofmir484isassociatedwithpoorprognosisandtumorprogressionofgastriccancer
AT xiaochengfan downregulationofmir484isassociatedwithpoorprognosisandtumorprogressionofgastriccancer